ArticleCancer immunology, immunotherapy : CII2016

Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.

Susan P Foy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.